The U.S. Food and Drug Administration (FDA) has fast-tracked an mRNA vaccine candidate for chlamydia.
“The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. The decision was based on the potential of the vaccine candidate to address
Continue reading

Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!